Category
Atropine
CAS Number
21956-47-8
Molecular Formula
C₁₇H₂₃NO₃
Molecular Weight
289.4 g/mol
Synonym

(1R,3r,5S)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl (R)-2-hydroxy-3-phenylpropanoate; (R)-(-)-Littorine ;(1R,3r,5S)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate;Littorine (EP & USP)

Keywords
Amines
Intermediates
Heterocycles
Fine Chemicals
Pharmaceutical Standards
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Atropine EP Impurity G (CAS No. 21956-47-8) is a specialized pharmaceutical impurity reference standard with the molecular formula C₁₇H₂₃NO₃ and molecular weight 289.4 g/mol. Manasa Lifesciences, an established Indian manufacturer and supplier, delivers Atropine EP Impurity G for pharmaceutical analytical research, quality assessment, impurity profiling, process research, method development, and formulation-related R&D. Our scientific team provides dependable analytical characterization and supporting documentation, including HPLC, LC-MS/MS, NMR, FTIR, qNMR, assay/potency evaluation, and COA, along with applicable GLP, GDP, ICH, EMA, USP, and EP quality and regulatory considerations. With a focus on trace-level impurity assessment, structural elucidation, analytical verification, and pharmaceutical quality management, Manasa Lifesciences supports laboratories and R&D organizations seeking consistent and scientifically reliable impurity-testing solutions.